Novo Nordisk faces FDA scrutiny over unreported Ozempic side effects, including deaths and a suicide, amid struggles to compete with Eli Lilly in the US obesity drug market. Despite risks like nausea and pancreatitis, Ozempic helps control blood sugar, slow d…
Danish drugmaker Novo Nordisk is now in focus and is facing scrutiny from the US Food and Drug Administration (FDA). On Tuesday (local time) said that it received a warning letter from the FDA for fa… [+3723 chars]
